Apkacef T 500mg/62.5mg Injection
Marketer
Apkavit Lifesciences
Salt Composition
Ceftriaxone (500mg) + Tazobactum (62.5mg)
Overview Apkacef T 500mg/62.5mg Injection
Ceftazidime/Tazobactam 500mg/62.5mg injection is a dual-action antibiotic used to combat diverse bacterial infections. Its mechanism involves inhibiting bacterial growth, thus curbing infection spread. Administration must always be overseen by a medical professional. Consistent adherence to the prescribed dosage schedule is crucial; completing the entire course is vital, even with symptom improvement. Premature cessation may compromise treatment efficacy. Typical side effects include nausea, vomiting, diarrhea, and digestive upset. Severe or worsening side effects necessitate immediate medical attention. Allergic reactions (skin rashes, itching, swelling, respiratory distress) require prompt emergency care. Inform your physician of all current medications before commencing treatment. Expectant or nursing mothers require prior medical consultation. Alcohol consumption should be avoided due to potential increased drowsiness. While generally not impairing driving ability, refrain from driving if drowsiness or dizziness occurs. Adequate rest, balanced nutrition, and hydration facilitate recovery. Your doctor may order blood tests and other diagnostics to monitor treatment response.
Uses of Apkacef T 500mg/62.5mg Injection
Infections caused by bacteria
Major Benefits of Apkacef T 500mg/62.5mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Apkacef T 500mg/62.5mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Apkacef T 500mg/62.5mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is not permitted.
How Apkacef T 500mg/62.5mg Injection works:
Ceftriaxone/Tazobactam (Apkacef T 500mg/62.5mg Injection) combines the antibiotic Ceftriaxone with the beta-lactamase inhibitor Tazobactam. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, thereby hindering bacterial survival. Tazobactam's role is to counteract bacterial resistance mechanisms, optimizing Ceftriaxone's antibacterial effect.
SAFETY ADVICE
AlcoholSAFE
Concurrent use of alcohol and Apkacef T 500mg/62.5mg Injection poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Apkacef T 500mg/62.5mg is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no negative consequences for fetal development; nevertheless, clinical data from human trials remain scarce.
Breast feedingCAUTION
The administration of Apkacef T 500mg/62.5mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's course of treatment and until the medication is fully cleared from her system.
DrivingUNSAFE
The injection Apkacef T (500mg/62.5mg) can cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Apkacef T 500mg/62.5mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
Individuals with significant hepatic impairment should use Apkacef T 500mg/62.5mg Injection cautiously, potentially requiring dosage modification. Medical advice is recommended. Dosage alteration for Apkacef T 500mg/62.5mg Injection isn't advised for those experiencing mild to moderate liver dysfunction.
What if you forget to take Apkacef T 500mg/62.5mg Injection :
Should you inadvertently omit a scheduled dose of Apkacef T 500mg/62.5mg Injection, seek guidance from your physician.
Facts to Know About Apkacef T 500mg/62.5mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently